Furthermore, the Bmi-1/miR-27a/RKIP and Bmi-1/miR-155/RKIP signaling axes might be potent targets for novel therapeutic approaches against human GC due to their demonstrated roles in tumor metastasis and drug resistance. This evidence concerns the gene PEBP1 and gastric cancer.